The Insight Partners published latest research study on “Medical Collagen Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Source, Product, and Application,” the market is expected to reach US$ 957.4 million by 2028 from US$ 593.7 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. The report highlights key driving factors and prominent market players along with their developments in the market.
Collagen is the most abundantly found protein in human body. It occurs mostly in fibrous tissues such as ligaments, skin, tendons, cornea, blood vessels, bones, cartilages, and intervertebral disc. Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry. The exponential increase in number of regenerative surgeries performed on patients to treat certain forms of skin cancers, burn injuries, birth defects, and congenital diseases is primarily expected to drive the demand for medical collagen.
Get Sample Copy with Complete TOC and Figures & Graphs @ https://www.theinsightpartners.com/sample/TIPRE00012952/
A medical product with collagen as a part are being studied to treat several conditions. Owing to its clinical and consumer acceptance, it is widely used as medical material. Collagen based medical products such as bioprosthetic heart valves, arterial replacements, sutures used in surgical procedures, and wound dressings have been widely used. Thus, several research studies are being conducted to develop new collagen-based medical products. For instance, in 2020, MPM Medical initiated its CoMatryx Surgical Bovine Collagen Study. CoMatryx surgical collagen powder is a soft tissue repair product, which is made of 100% Type-I Bovine collagen.
Further, research is also being conducted to discover new sources of collagen for medical biomaterials. For instance, the study ‘Tilapia (Oreochromis aureus) Collagen for Medical Biomaterials’ was published in 2018. In this study, the researchers studied the potential of tilapia skin as an alternative source of collagen for its application in medical biomaterial.
Thus, increasing research activities for collagen-based medical products is likely to favor the growth of the market during the forecast period.
Have a Question? Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00012952
Market leaders operating in the market have undertaken various organic growth strategies in the medical collagen market. The medical collagen majorly consists of the players such as as DSM, Integra Lifesciences Corporation, Collagen Matrix, Inc., Encoll, Collagen Solutions Plc, Innocoll, Symatese, Gelita Ag, Collplant Biotechnologies Ltd, and Croda Interntional PLC. Some of the activities undertaken by the company, which have promoted its growth are, product launch, approvals, partnership and strategy and business planning. Companies such as Bayer AG, Cupid Limited and others have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market.
Browse key market insights spread across 172 pages with 84 list of tables & 76 list of figures from the report, “Medical Collagen Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Source (Bovine, Porcine, and Others), Product (Gelatine, Hydrolysed Collagen, Native Collagen, and Others), and Application (Wound Care, Bone Grafts, Tissue Scaffolds, Cartilage Repair, Haemostats, Diagnostics, Vascular Grafts, and Others)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/medical-collagen-market
Below is the list of the growth strategies done by the players operating in the medical collagen market:
In Oct 2020, Innocoll has launched XARACOLL (bupivacaine HCI) implant. It is a collagen derived implant indicated for postsurgical pain relief. XARACOLL is a unique, non-injectable, drug-device combination in the form of a fully bioresorbable collagen implant containing bupivacaine hydrochloride. This product is approved by US FDA in August 2020.
In April 2019, Collagen Matrix, Inc. ha received the FDA 510(k) clearance for its innovative line of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix through its Spine business unit.
In Feb 2018, Collagen Matrix, Inc. has launched two product lines, OssiMend® bone graft matrices from its Spine Business Unit and DuraMatrix® membranes from its Dural Repair Business Unit in India. OssiMend bone graft matrices are designed to provide a scaffold for a patient to grow new bone and are typically used in spinal fusion surgeries. DuraMatrix Dural repair products are engineered to provide a scaffold for brain and spinal cord host dura to naturally regenerate resulting in the protection, closure, and repair of dural defects as well as providing leak resistance of cerebrospinal fluid.
In Jul 2020, Collagen Solutions Plc and NovaBone has entered into new minimum three-year collaboration agreement for supply of specialized collagen biomaterials specific to their line of bone graft products used in orthopedic and dental applications.
In April 2017, Collagen Solutions PLC and Smart Matrix Limited has entered into partnership agreement for development and manufacturing of medical grade collagen components for use in regenerative medicine, medical devices, and in-vitro diagnostics.
Geographically, the medical collagen market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America held the largest market share in 2019. In North America, the US is the largest market for medical collagen. The market growth in the region is attributed to the presence of key market players and their product developments. In addition, the escalating demand for medical collagen used in reconstructive surgery, tissue engineering, bone grafts, and treating wounds and burn injuries is propelling the growth of the market in North America.
Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPRE00012952/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi